CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income	$ 2,473,078	$ 151,469
Adjustments necessary to reconcile net income to net cash (used in) operating activities:
Depreciation and amortization	44,400	49,311
Accrued interest on note receivable	(13,654)	0
Stock based compensation expense	46,581	81,219
Accrued sales allowance	(94,203)	(196,978)
(Increase) decrease in accounts receivable	(6,755,174)	(6,376,672)
(Increase) decrease in inventory	(275,049)	38,337
(Increase) decrease in prepaid expenses	43,764	(371,317)
(Increase) decrease in other assets	0	14,456
Increase (decrease) in accounts payable and accrued liabilities	958,580	1,167,729
Increase (decrease) in accrued interest on notes payable	(168,492)	148,385
Net cash (used in) operating activities	(3,740,169)	(5,294,061)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(15,501)	(58,194)
Net cash (used in) investing activities	(15,501)	(58,194)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from notes payable	19,393,834	5,791,914
Repayments of notes payable	(15,049,345)	(1,895,194)
Proceeds from notes and loans payable to related parties	860,000	2,500,000
Repayments of notes and loans payable to related parties	(1,453,946)	(1,100,000)
Net cash provided by financing activities	3,750,543	5,296,720
Net (Decrease) in Cash and Cash Equivalents	(5,127)	(55,535)
Cash and Cash Equivalents at Beginning of Period	364,714	313,856
Cash and Cash Equivalents at End of Period	359,587	258,321
Cash paid during the period for:
Interest	396,014	57,549
Income taxes	31,912	0
Total Cash paid during the period	427,926	57,549
Non-cash financing and investing activities:
Conversion of Series C Preferred Stock to Common Stock	0	1,000
Sale of Investment for Note receivable	$ 500,000	$ 0